STAT July 27, 2022
It’s a problem so complex, so fraught with stigma and treatment complications, that innovation has crept forward slowly even as a crisis escalates: suicide prevention.
But for several years, a small New Haven, Conn.-based startup has quietly been building technology to move the needle on suicide rates among the people at highest risk: those with a history of attempts or who have suicidal thoughts and have expressed a strong desire to die.
The company, called Oui Therapeutics, has raised roughly $26 million from high-profile investors like CVS Health Ventures and First Round Capital to develop and launch an app designed to train people how to quell their suicidal impulses. It pulls from in-person therapy methods that have shown dramatic reductions...
Today's Sponsors
Today's Sponsor